News

Deal Announcements

Actinium Pharma Adds Venture Capital Funding

Thursday, January 23, 2014 5:54:00 AM PDT | VentureDeal
   New York, NY  --  Actinium Pharmaceuticals has landed $3.3 million in new venture capital investment, according to an SEC filing.

Actinium is developing alpha particle linked antibodies to treat cancer.

Investors in the financing were not disclosed, nor was how the company intends to use the proceeds.

Minimum investment was $5,000 per investor, according to the filing.

Email Page  Email Page | Print Page Print Page

Free Trial

Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?

Start your Free 14 Day Trial now – no obligation or credit card required.

Free 14 day trial. No Obligation. Click to Register.
Venturedeal Twitter Venturedeal Facebook Venturedeal Linkedin


PCI - Level1